Home » Tenders » Europe » Croatia » Purchase of Drugs Trastusumab Deruxtecan and Human Alpha 1 Proteinase Inhibitor Tender

Purchase of Drugs Trastusumab Deruxtecan and Human Alpha 1 Proteinase Inhibitor Tender

Download Documents

OSIJEK CLINICAL HOSPITAL CENTER has floated a tender for Purchase of Drugs Trastusumab Deruxtecan and Human Alpha 1 Proteinase Inhibitor. The project location is Croatia and the tender is closing on 19 Apr 2024. The tender notice number is 175024-2024, while the TOT Ref Number is 99187140. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Croatia

Summary : Purchase of Drugs Trastusumab Deruxtecan and Human Alpha 1 Proteinase Inhibitor

Deadline : 19 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99187140

Document Ref. No. : 175024-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : EUR 68100.00

Purchaser's Detail

Purchaser : OSIJEK CLINICAL HOSPITAL CENTER
Address: Ulica Josipa Huttlera 4
Town: Osijek
NUTS-Code: HR025
Postal Code: 31000
Attn: Boris Flegar, dipl. oec.
Phone: 385 31511111
Croatia
Email :javna.nabava@kbco.hr
URL :https://www.kbco.hr/

Tender Details

The subject of procurement are medicines included in the List of Medicines of HZZO, classified by ATK code, for the needs of KBC Osijek in a one-year period

1. group

drug trastuzumab deruxtecan

2. group

drug alpha 1 proteinase inhibitor

Doc Title: PURCHASE OF DRUGS TRASTUSUMAB DERUXTECAN AND HUMAN INHIBITOR ALFA 1 PROTEINAZE

Contract Type: supplies
Document Type: Contract Notice
Reference Number: VV-24/20
Contract Type: supplies
Estimated Value: 68100.00 - EUR
Authority Type: body-pl-cga
Doc Title: NABAVA LIJEKOVA TRASTUZUMAB DERUKSTEKAN I LJUDSKI INHIBITOR ALFA 1 PROTEINAZE
Dispatch Date: 2024-03-20
Publish Date: 2024-03-22
Submission Date: 2024-04-19